Back to Search
Start Over
Inflammation-Induced Attenuation of Prostaglandin D 2 Elimination across Rat Blood-Brain Barrier: Involvement of the Downregulation of Organic Anion Transporter 3 and Multidrug Resistance-Associated Protein 4.
- Source :
-
Biological & pharmaceutical bulletin [Biol Pharm Bull] 2020; Vol. 43 (11), pp. 1669-1677. - Publication Year :
- 2020
-
Abstract
- Prostaglandin (PG) D <subscript>2</subscript> is a lipid mediator, and in the brain, overproduction of PGD <subscript>2</subscript> is reportedly involved in the progression and exacerbation of neuroinflammation. The objective of this study was to elucidate PGD <subscript>2</subscript> efflux transport, under normal and inflammatory conditions, across the blood-brain barrier (BBB), which is formed by brain capillaries. Elimination of [ <superscript>3</superscript> H]PGD <subscript>2</subscript> across the BBB of normal and lipopolysaccharide (LPS)-induced inflammatory rats was examined by the intracerebral microinjection technique. After intracerebral injection, the percentage of [ <superscript>3</superscript> H]PGD <subscript>2</subscript> remaining in the ipsilateral cerebrum decreased with time, with a half-life of 13 min. This [ <superscript>3</superscript> H]PGD <subscript>2</subscript> elimination across the BBB was significantly inhibited by the co-administration of unlabeled PGD <subscript>2</subscript> , which suggests carrier-mediated PGD <subscript>2</subscript> efflux transport at the BBB. In isolated rat brain capillaries, mRNA expression of organic anion transporter (Oat) 3, organic anion-transporting polypeptide (Oatp) 1a4, and multidrug resistance-associated protein (Mrp) 4 was observed. In addition, co-administration of substrates/inhibitors for Oat3, Oatp1a4, and/or Mrp4, such as benzylpenicillin and cefmetazole, reduced [ <superscript>3</superscript> H]PGD <subscript>2</subscript> elimination across the BBB. Data suggest that Oat3 and Mrp4, but not Oatp1a4 are involved in PGD <subscript>2</subscript> elimination across the BBB, as Oatp1a4-expressing Xenopus (X.) oocytes did not show the significant [ <superscript>3</superscript> H]PGD <subscript>2</subscript> uptake compared with water-injected X. oocytes. In LPS-treated rats, [ <superscript>3</superscript> H]PGD <subscript>2</subscript> elimination across the BBB and mRNA expression levels of Oat3 and Mrp4 were significantly decreased. Our data suggest that Oat3- and Mrp4-mediated PGD <subscript>2</subscript> elimination across the BBB is attenuated under inflammatory conditions.
- Subjects :
- Animals
Blood-Brain Barrier drug effects
Blood-Brain Barrier immunology
Brain Diseases pathology
Cefmetazole administration & dosage
Disease Models, Animal
Down-Regulation immunology
Humans
Inflammation immunology
Inflammation pathology
Lipopolysaccharides administration & dosage
Lipopolysaccharides immunology
Male
Microinjections
Multidrug Resistance-Associated Proteins antagonists & inhibitors
Oocytes
Organic Anion Transporters, Sodium-Independent antagonists & inhibitors
Penicillin G administration & dosage
Rats
Xenopus laevis
Blood-Brain Barrier pathology
Brain Diseases immunology
Multidrug Resistance-Associated Proteins metabolism
Organic Anion Transporters, Sodium-Independent metabolism
Prostaglandin D2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1347-5215
- Volume :
- 43
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Biological & pharmaceutical bulletin
- Publication Type :
- Academic Journal
- Accession number :
- 33132311
- Full Text :
- https://doi.org/10.1248/bpb.b20-00388